结论：在1型糖尿病肾病患者中，血adma的水平对致命和非致命的心血管事件有预测作用。
Conclusions: Plasma ADMA levels predict fatal and non-fatal cardiovascular events in patients with type 1 nephropathy.
原因在于慢性肾病患者似乎对心血管疾病的保护措施反应尤为敏锐。
The reason for this is that these people with chronic kidney disease seem to be particularly responsive to global protection of cardiovascular disease.
预测因子与2型糖尿病肾病和高血压患者心血管事件的预测因子：蛋白尿因素。
Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria.
这可能具有重要的临床意义，因为多数慢性肾病患者死于心血管疾病。
This could have important clinical implications because most patients with chronic kidney disease die from cardiovascular causes.
特尿病合并高血压者心血管疾病和脑卒中的危险性增加1倍。 发生终末阶段肾病的危险增加5~6倍。
Urinates especially sickness merge hypertension cardiovascular disease and the apoplexy risk increases 1 time. has end the stage nephrosis danger to increase 5~6 times finally.
巨量白蛋白尿的患者组，其肾病进展的危险因素与微量白蛋白尿组相似，其进展的患者肾小球滤过率较低（GFRs）且诊断有心血管疾病或心力衰竭。
The macroalbuminuria group had risk factors similar to the microalbuminuria group, and had lower glomerular filtration rates (GFRs) and a diagnosis of cardiovascular disease or heart failure.
慢性肾病患者通常合并存在代谢综合症，这种相关性在出现明显的心血管疾病临床表现之前可能已经显而易见。
Chronic kidney disease coexists with metabolic syndrome and this relationship may be apparent before overt manifestations of cardiovascular disease.
另外，慢性肾病会增加发生心血管疾病的风险、死亡率和药物副作用。
In addition, chronic kidney disease increases the risk of cardiovascular diseases, mortality and medication side-effects.
内皮素1可促进慢性肾病的发生与进展，与心血管疾病相关。
Endothelin 1 promotes the development and progression of chronic kidney disease and associated cardiovascular disease.
微量白蛋白尿是糖尿病肾病发病的首要指征，也是早期出现心血管疾病的重要指征之一，可提示微血管病变。
Microalbuminuria is the first sign of the pathogenesis of diabetic nephropathy. It is also an important marker of early development of cardiovascular disease and can indicate microvascular disease.
在中国，百分之八十的死亡是由慢性疾病导致的。例如心血管病，脑卒中与肾病。预计在未来数十年内，由慢性疾病导致的死亡数会持续上升。
Chronic diseases such as heart attacks, strokes and kidney disease, cause 80 per cent of deaths in China, and these are projected to rise considerably over the coming decade.
结果非透析CRF患者的心血管并发症的总发病率为41.51%，其中慢性肾小球肾炎CRF、高血压肾病CRF、糖尿病肾病CRF并发心血管疾病的比例分别为26.62%、6.92%和5.45%；
Results The total incidence was 41.51% in non-dialysis CRF patients, 26.62%, 6.92% and 5.45% in glomerulonephritis CRF, hypertensive CRF and diabetic CRF respectively;
结果非透析CRF患者的心血管并发症的总发病率为41.51%，其中慢性肾小球肾炎CRF、高血压肾病CRF、糖尿病肾病CRF并发心血管疾病的比例分别为26.62%、6.92%和5.45%；
Results The total incidence was 41.51% in non-dialysis CRF patients, 26.62%, 6.92% and 5.45% in glomerulonephritis CRF, hypertensive CRF and diabetic CRF respectively;
应用推荐